Tekla Capital Management’s Amicus Therapeutics FOLD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
-587,277
| Closed | -$5.61M | – | 175 |
|
|
2021
Q3 | $5.61M | Sell |
587,277
-34,382
| -6% | -$328K | 0.18% | 100 |
|
|
2021
Q2 | $5.99M | Hold |
621,659
| – | – | 0.19% | 111 |
|
|
2021
Q1 | $6.14M | Buy |
621,659
+216,033
| +53% | +$2.13M | 0.21% | 105 |
|
|
2020
Q4 | $9.37M | Hold |
405,626
| – | – | 0.33% | 83 |
|
|
2020
Q3 | $5.73M | Buy |
405,626
+68,642
| +20% | +$969K | 0.21% | 103 |
|
|
2020
Q2 | $5.08M | Sell |
336,984
-31,976
| -9% | -$482K | 0.19% | 100 |
|
|
2020
Q1 | $3.41M | Hold |
368,960
| – | – | 0.15% | 108 |
|
|
2019
Q4 | $3.59M | Buy |
368,960
+54,363
| +17% | +$530K | 0.14% | 129 |
|
|
2019
Q3 | $2.52M | Hold |
314,597
| – | – | 0.11% | 124 |
|
|
2019
Q2 | $3.93M | Hold |
314,597
| – | – | 0.16% | 103 |
|
|
2019
Q1 | $4.28M | Sell |
314,597
-560,707
| -64% | -$7.63M | 0.17% | 102 |
|
|
2018
Q4 | $8.39M | Hold |
875,304
| – | – | 0.36% | 59 |
|
|
2018
Q3 | $10.6M | Hold |
875,304
| – | – | 0.38% | 62 |
|
|
2018
Q2 | $13.7M | Hold |
875,304
| – | – | 0.52% | 43 |
|
|
2018
Q1 | $13.2M | Buy |
875,304
+270,384
| +45% | +$4.07M | 0.51% | 45 |
|
|
2017
Q4 | $8.71M | Buy |
604,920
+329,426
| +120% | +$4.74M | 0.34% | 61 |
|
|
2017
Q3 | $4.15M | Buy |
275,494
+114,764
| +71% | +$1.73M | 0.15% | 94 |
|
|
2017
Q2 | $1.62M | Sell |
160,730
-258,000
| -62% | -$2.6M | 0.06% | 118 |
|
|
2017
Q1 | $2.99M | Hold |
418,730
| – | – | 0.12% | 96 |
|
|
2016
Q4 | $2.08M | Buy |
418,730
+160,730
| +62% | +$799K | 0.09% | 107 |
|
|
2016
Q3 | $1.91M | Hold |
258,000
| – | – | 0.07% | 118 |
|
|
2016
Q2 | $1.41M | Hold |
258,000
| – | – | 0.06% | 126 |
|
|
2016
Q1 | $2.18M | Buy |
+258,000
| New | +$2.18M | 0.09% | 118 |
|